Data / Form D filings / Lonestar Medicines, Inc.
Lonestar Medicines, Inc.: Form D filing
Lonestar Medicines, Inc., a biotechnology company in Boston, MA, filed a Form D with the SEC in 2026. The latest, on February 23, 2026, reports $25 million sold of a $45 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 BERKELEY STREET 18TH FLOOR, Boston, MA, 02116
- Phone
- (518) 313-0994
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2111460
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | New notice | $45,000,000 | $25,000,000 | $20,000,000 | 4 | Jan 12, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stephen Basil Thomas | Executive Officer, Director, Promoter | |
| William Daley Bonificio | Executive Officer, Promoter | |
| Naveen Manu Daryani | Executive Officer | |
| Andrew Levin | Director | |
| Gianna Hoffman-Luca | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Feb 23, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Lonestar Medicines, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.